These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8733890)
1. Effect of erucic acid on platelets in patients with adrenoleukodystrophy. Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890 [TBL] [Abstract][Full Text] [Related]
2. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883 [TBL] [Abstract][Full Text] [Related]
3. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy. Ahmed MA; Kartha RV; Brundage RC; Cloyd J; Basu C; Carlin BP; Jones RO; Moser AB; Fatemi A; Raymond GV Br J Clin Pharmacol; 2016 Jun; 81(6):1058-66. PubMed ID: 26836218 [TBL] [Abstract][Full Text] [Related]
4. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy. Zinkham WH; Kickler T; Borel J; Moser HW N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677 [No Abstract] [Full Text] [Related]
5. Thrombocytopenia associated with use of Lorenzo's oil. Chai BC; Siminoski K Am J Hematol; 1993 Dec; 44(4):290-1. PubMed ID: 8238006 [No Abstract] [Full Text] [Related]
6. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil. Tanaka M; Koike R; Kuwabara T Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141 [No Abstract] [Full Text] [Related]
7. Platelets in treated adrenoleukodystrophy: a brief report. Revell P; Green A; Green S J Inherit Metab Dis; 1995; 18(5):635-7. PubMed ID: 8598646 [TBL] [Abstract][Full Text] [Related]